Influence of polymorphisms in CYP2C9, VKORC1, MDR1 and APOE genes on the warfarin maintenance dose in Brazilian patients

被引：1
|
作者：
Campos, Emilio Itamar de Freitas [1 ]
Gomes, Karina Braga [2 ]
Ribeiro, Daniel Dias [3 ]
Puurunen, Marja Kaarina [4 ]
Mourao, Aline deOliveira Magalhaes [1 ]
Ferreira, Isadora Goncalves [2 ]
Rocha, Manoel Otavio da Costa [1 ,3 ]
de Souza, Renan Pedra [5 ]
Martins, Maria Auxiliadora Parreiras [1 ,2 ,3 ]
机构：
[1] Univ Fed Minas Gerais, Fac Med, Ave Prof Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil
[2] Univ Fed Minas Gerais, Fac Farm, Ave Pres Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Hosp Clin, Ave Prof Alfredo Balena 110, BR-30130100 Belo Horizonte, MG, Brazil
[4] Boston Univ, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA
[5] Univ Fed Minas Gerais, Inst Ciencias Biol, Ave Pres Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil
来源：
PHARMACOGENOMICS | 2023年 / 24卷 / 13期
关键词：
APOE; genetic polymorphism; MDR1; VKORC1; warfarin; DOSING ALGORITHM; C3435T POLYMORPHISM; ORAL ANTICOAGULANT; REQUIREMENTS; DOSAGE; SUSCEPTIBILITY; SENSITIVITY; POPULATION; INTENSITY; GENOTYPE;
D O I：
10.2217/pgs-2023-0099
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Background: Polymorphisms in the CYP2C9, VKORC1, MDR1 and APOE genes may impact warfarin dose. Aim: To investigate the influence of sociodemographic and clinical factors and polymorphisms *1, *2 and *3 for CYP2C9, -1639G > A for VKORC1, 3435C > T for MDR1, and epsilon 2, epsilon 3 and epsilon 4 for APOE genes on the mean weekly warfarin maintenance dose in adults. Methods: This cross-sectional study recruited a calculated sample of 315 patients in three anticoagulation clinics in Brazil. A model containing the variables significantly associated with warfarin dose was estimated. Results: Themean age of patients was 64.1 +/- 13.1 years, with 173 (54.9%) women. Age, use of amiodarone, genotype VKORC1 GA, genotype VKORC1 AA, genotypes CYP2C9*1/*2 or *1/*3 and genotypes CYP2C9*2/*2 or *2/*3 or *3/*3 were associated with a reduced warfarin dose. Conclusion: This study pointed out factors that could impact the management of oral anticoagulation.
引用
收藏
页码：701 / 712
页数：12
相关论文
共 50 条
  • [1] Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 Genes and the Therapeutic Warfarin Dose in Brazilian Patients with Thrombosis: A Prospective Cohort Study
    Vanessa Cristina de Oliveira Almeida
    Daniel Dias Ribeiro
    Karina Braga Gomes
    Ana Lúcia Brunialti Godard
    Molecular Diagnosis & Therapy, 2014, 18 : 675 - 683
  • [2] Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 Genes and the Therapeutic Warfarin Dose in Brazilian Patients with Thrombosis: A Prospective Cohort Study
    de Oliveira Almeida, Vanessa Cristina
    Ribeiro, Daniel Dias
    Gomes, Karina Braga
    Brunialti Godard, Ana Lucia
    MOLECULAR DIAGNOSIS & THERAPY, 2014, 18 (06) : 675 - 683
  • [3] Association between polymorphisms of the VKORC1 and CYP2C9 genes and warfarin maintenance dose in Peruvian patients
    Oscanoa, Teodoro J.
    Guevara-Fujita, Maria L.
    Fujita, Ricardo M.
    Munoz-Paredes, Maria Y.
    Acosta, Oscar
    Romero-Ortuno, Roman
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (03) : 769 - 775
  • [4] The effects of CYP2C9 and VKORC1 gene polymorphisms on warfarin maintenance dose in Turkish cardiac patients
    Akdeniz, Cansu Selcan
    Cevik, Mehtap
    Canbolat, Ismail Polat
    Yurdakul, Selen
    Cagatay, Penbe
    Ciftci, Cavlan
    Karaalp, Atila
    Susleyici, Belgin
    FUTURE CARDIOLOGY, 2020, 16 (06) : 645 - 654
  • [5] Warfarin sensitivity and CYP2C9 and VKORC1 genes
    Bukaveckas, Bonny Lewis
    INFLAMMATION RESEARCH, 2007, 56 : S223 - S224
  • [6] VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
    G. Oner Ozgon
    T. Y. Langaee
    H. Feng
    N. Buyru
    T. Ulutin
    A. C. Hatemi
    A. Siva
    S. Saip
    J. A. Johnson
    European Journal of Clinical Pharmacology, 2008, 64 : 889 - 894
  • [7] VKORC1 and CYP2C9 polymorphisms are associated with warfarin dose requirements in Turkish patients
    Ozgon, G. Oner
    Langaee, T. Y.
    Feng, H.
    Buyru, N.
    Ulutin, T.
    Hatemi, A. C.
    Siva, A.
    Saip, S.
    Johnson, J. A.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (09) : 889 - 894
  • [8] Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
    Taisei Mushiroda
    Yozo Ohnishi
    Susumu Saito
    Atsushi Takahashi
    Yuka Kikuchi
    Shigeru Saito
    Hideki Shimomura
    Yasuhiko Wanibuchi
    Takao Suzuki
    Naoyuki Kamatani
    Yusuke Nakamura
    Journal of Human Genetics, 2006, 51 : 249 - 253
  • [9] Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
    Mushiroda, T
    Ohnishi, Y
    Saito, S
    Takahashi, A
    Kikuchi, Y
    Saito, S
    Shimomura, H
    Wanibuchi, Y
    Suzuki, T
    Kamatani, N
    Nakamura, Y
    JOURNAL OF HUMAN GENETICS, 2006, 51 (03) : 249 - 253
  • [10] Frequency of CYP2C9 and VKORC1 Gene Polymorphisms and Their Influence on Warfarin Dose in Egyptian Pediatric Patients
    Mennat-Allah Kamal El-Din
    Marwa Salah Farhan
    Randa Ibrahim El Shiha
    Rania Mohammed Helmy El-Kaffas
    Somaia Mohammed Mousa
    Pediatric Drugs, 2014, 16 : 337 - 341
12345